be seen studybe seen study

BE SEEN – a study to learn more about palmoplantar pustulosis (PPP)

Does PPP leave you feeling isolated? If you have been diagnosed with palmoplantar pustulosis, or PPP, you might be interested in the BE SEEN Study, which is evaluating an investigational drug called bimekizumab in people living with this condition

About Clinical Research

About Clinical Research

Clinical research helps doctors find better ways to treat diseases. Before any new medicine can be given to people, it has to be tested in studies to find out how well tolerated the medicine is and if it works well.

Read more
About the BE SEEN Study

About the BE SEEN Study

The BE SEEN Study is looking at a drug called bimekizumab to see if it can help people with PPP. The main goal is to find out how well tolerated the drug is and if it works well to treat PPP symptoms.

Read more

The most important people in clinical research are volunteers.

Without people like you, clinical studies could not take place.

Why the BE SEEN Study?

Treatment options for palmoplantar pustulosis are limited, even though this condition severely impacts the lives of those affected by it. With the BE SEEN Study we are aiming to close that gap. 

This website provides information about the BE SEEN Study, a clinical study sponsored by UCB Biopharma SRL. It is evaluating an investigational drug compared with placebo in people with PPP. Information placed on this website is not intended as a substitute for consultation with your healthcare professional. For further information about the disease described on this website or treatment options for PPP, please consult your treating doctor.